Lv5
996 积分 2025-03-13 加入
Targeting ALPPL2 with a novel CD89 bispecific antibody reprograms macrophages to enhance anti-tumor immunity
3小时前
已完结
In silico identification and experimental validation of long-range allosteric inhibition of Staphylococcus aureus Cas9 catalytic activity by an anti-CRISPR protein AcrIIA14
26天前
已完结
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
1个月前
已完结
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
1个月前
已完结
A soluble form of the adhesion receptor CD58 (LFA‐3) is present in human body fluids
1个月前
已完结
Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2)
1个月前
已完结
TIGIT’s immuno-oncology teachings
1个月前
已完结
Characterization of an anti-STEAP1 T-Cell Dependent Bispecific Antibody for the Treatment of Prostate Cancer and Associated Toxicity in Cynomolgus Monkeys
2个月前
已完结
Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
2个月前
已完结
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
2个月前
已完结